Page last updated: 2024-09-05

ly 293111 and amelubant

ly 293111 has been researched along with amelubant in 1 studies

Compound Research Comparison

Studies (ly 293111)	Trials (ly 293111)	Recent Studies (post-2010) (ly 293111)	Studies (amelubant)	Trials (amelubant)	Recent Studies (post-2010) (amelubant)
38	9	6	10	3	4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderskewitz, R; Birke, FW; Jennewein, HM; Meade, CJ; Speck, GA	1

Other Studies

1 other study(ies) available for ly 293111 and amelubant

Article	Year
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1 Topics: Amidines; Animals; Anti-Inflammatory Agents; Benzoates; Calcium; Carbamates; Cell Line; Chemotaxis, Leukocyte; Guinea Pigs; Humans; Leukotriene B4; Macrophage-1 Antigen; Neutrophils; Rabbits; Rats; Receptors, Leukotriene B4; Species Specificity; Succinates	2001

Article

Year

In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.

The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1

Topics: Amidines; Animals; Anti-Inflammatory Agents; Benzoates; Calcium; Carbamates; Cell Line; Chemotaxis, Leukocyte; Guinea Pigs; Humans; Leukotriene B4; Macrophage-1 Antigen; Neutrophils; Rabbits; Rats; Receptors, Leukotriene B4; Species Specificity; Succinates

2001